| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2019-11-08 | VANGUARD GROUP INC | PUMA BIOTECHNOLOGY, INC. | 3,905,523 | 10.0% | EDGAR |
| SC 13G/A | 2019-07-10 | STATE STREET CORP | PUMA BIOTECHNOLOGY, INC. | - | 12.3% | EDGAR |
| SC 13G/A | 2019-05-14 | GREAT POINT PARTNERS LLC | PUMA BIOTECHNOLOGY, INC. | 1,096,626 | 2.8% | EDGAR |
| SC 13G | 2019-05-14 | GREAT POINT PARTNERS LLC | PUMA BIOTECHNOLOGY, INC. | 1,970,000 | 5.1% | EDGAR |
| SC 13G | 2019-03-18 | Partner Fund Management, L.P. | PUMA BIOTECHNOLOGY, INC. | - | 6.8% | EDGAR |
| SC 13D/A | 2019-02-14 | AUERBACH ALAN H | PUMA BIOTECHNOLOGY, INC. | 7,258,211 | 17.6% | EDGAR |
| SC 13G/A | 2019-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | PUMA BIOTECHNOLOGY, INC. | 4,485 | 0.0% | EDGAR |
| SC 13G/A | 2019-02-14 | Partner Fund Management, L.P. | PUMA BIOTECHNOLOGY, INC. | - | 0.0% | EDGAR |
| SC 13G/A | 2019-02-13 | ADAGE CAPITAL PARTNERS GP, L.L.C. | PUMA BIOTECHNOLOGY, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2019-02-13 | ORBIMED ADVISORS LLC | PUMA BIOTECHNOLOGY, INC. | 535,046 | 1.4% | EDGAR |
| SC 13G | 2019-02-13 | STATE STREET CORP | PUMA BIOTECHNOLOGY, INC. | - | 7.5% | EDGAR |
| SC 13G/A | 2019-02-12 | VANGUARD GROUP INC | PUMA BIOTECHNOLOGY, INC. | 2,794,737 | 7.3% | EDGAR |
| SC 13G/A | 2019-02-11 | JANUS HENDERSON GROUP PLC | PUMA BIOTECHNOLOGY, INC. | 1,861,944 | 4.9% | EDGAR |
| SC 13G/A | 2019-02-06 | BlackRock Inc. | PUMA BIOTECHNOLOGY, INC. | 2,665,886 | 7.0% | EDGAR |
| SC 13G/A | 2018-10-10 | JANUS HENDERSON GROUP PLC | PUMA BIOTECHNOLOGY, INC. | 2,146,460 | 5.6% | EDGAR |
| SC 13G/A | 2018-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | PUMA BIOTECHNOLOGY, INC. | 1,976,517 | 5.2% | EDGAR |
| SC 13G/A | 2018-02-13 | STATE STREET CORP | PUMA BIOTECHNOLOGY, INC. | - | 3.2% | EDGAR |
| SC 13G/A | 2018-02-13 | FMR LLC | PUMA BIOTECHNOLOGY, INC. | 1,708,252 | 4.6% | EDGAR |
| SC 13G/A | 2018-02-13 | ADAGE CAPITAL PARTNERS GP, L.L.C. | PUMA BIOTECHNOLOGY, INC. | 2,222,500 | 5.9% | EDGAR |
| SC 13G/A | 2018-02-13 | ORBIMED ADVISORS LLC | PUMA BIOTECHNOLOGY, INC. | 945,689 | 2.5% | EDGAR |